FDA Inspection
Chongqing Huapont Shengchem Pharmaceutical Co LtdChongqing Huapont Shengchem Pharmaceutical Co Ltd – FDA Inspection, Jul 19, 2018
Record Details
This FDA Inspection record concerns Chongqing Huapont Shengchem Pharmaceutical Co Ltd, with an inspection on July 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 19, 2018
- Product Type
- Drugs
View Company Profile
ID · eb955bae-9345-46d4-b5e3-afb13447e996
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1063451
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chongqing Huapont Shengchem Pharmaceutical Co Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 1, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chongqing Huapont Shengchem Pharmaceutical Co Ltd
- FDA Inspection 1244293 - 2024-06-21
- FDA Inspection 944071 - 2015-09-23
- FDA Inspection 806744 - 2012-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.